Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| FBRX | FORTE BIOSCIENCES INC | $373.93M | 12,526,935 | 62.65% | 37.35% | Net Buying | Net Buying | ||
| CEVA | CEVA INC | $540.64M | 24,017,805 | 69.22% | 30.78% | Net Buying | |||
| AKA | AKA BRANDS HOLDING CORP | $120.07M | 10,739,676 | 4.11% | 95.89% | Net Selling | Net Selling | ||
| CGTX | COGNITION THERAPEUTICS INC | $109.46M | 88,274,258 | 24.09% | 29.34% | Net Selling | Net Selling | ||
| CRVO | CERVOMED INC | $49.96M | 9,252,719 | 2.96% | 97.04% | Net Buying | Net Buying | ||
| KYMR | KYMERA THERAPEUTICS INC | $5.12B | 71,949,027 | 75.15% | 24.85% | Net Buying | Net Buying | ||
| CSTL | CASTLE BIOSCIENCES INC | $1.15B | 29,188,659 | 85.50% | 14.50% | Net Selling | Net Selling | ||
| ZGN | ERMENEGILDO ZEGNA NV | $2.25B | 254,089,368 | 23.18% | 0.00% | ||||
| ABVX | ABIVAX SA | $8.31B | 72,944,298 | 71.24% | 0.00% | ||||
| HELP | CYBIN INC | $164.23M | 23,033,127 | 40.05% | 0.00% | ||||
| TYRA | TYRA BIOSCIENCES INC | $1.66B | 53,372,098 | 62.04% | 37.96% | Net Buying | Net Selling | ||
| CLFD | CLEARFIELD INC | $414.20M | 13,839,096 | 61.07% | 38.93% | Net Selling | Net Selling | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $188.91M | 59,500,000 | 60.11% | 0.00% | ||||
| IMTX | IMMATICS NV | $1.18B | 121,563,829 | 76.04% | 0.00% | ||||
| MBX | MBX BIOSCIENCES INC | $1.61B | 44,902,302 | 44.24% | 55.76% | Net Buying | |||
| SPWH | SPORTSMAN's WAREHOUSE HOLDINGS INC | $55.41M | 38,481,095 | 40.84% | 59.16% | Net Buying | Net Selling | ||
| SLDB | SOLID BIOSCIENCES INC | $510.31M | 77,910,239 | 55.42% | 44.58% | Net Buying | Net Selling | ||
| CRVS | CORVUS PHARMACEUTICALS INC | $1.53B | 74,681,872 | 55.80% | 41.58% | Net Buying | |||
| TERN | TERNS PHARMACEUTICALS INC | $3.09B | 90,079,781 | 81.05% | 18.95% | Net Selling | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $700.05M | 59,076,259 | 55.52% | 44.48% | Net Buying | Net Selling | ||
| CBC | CENTRAL BANCOMPANY INC | N/A | 238,442,900 | 0.00% | 2.15% | Net Buying | Net Buying | ||
| GHI | GREYSTONE HOUSING IMPACT INVESTORS LP | $181.82M | 23,582,453 | 8.18% | 26.64% | Net Buying | Net Selling | ||
| NRIX | NURIX THERAPEUTICS INC | $1.84B | 102,843,012 | 82.43% | 8.24% | Net Selling | Net Selling | ||
| ORIC | ORIC PHARMACEUTICALS INC | $1.07B | 97,389,279 | 83.26% | 16.74% | Net Selling | Net Selling | ||
| TRVI | TREVI THERAPEUTICS INC | $1.35B | 128,230,134 | 41.41% | 58.59% | Net Buying | Net Buying | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $1.69B | 68,659,923 | 72.98% | 27.02% | Net Selling | Net Selling | ||
| UPB | UPSTREAM BIO INC | $1.64B | 54,038,591 | 70.96% | 29.04% | ||||
| OKLO | OKLO INC | $14.75B | 156,247,075 | 41.46% | 39.51% | Net Selling | Net Selling | ||
| NTSK | NETSKOPE INC | $6.33B | 393,258,861 | 35.83% | 11.96% | Net Buying | Net Selling | ||
| LUCK | LUCKY STRIKE ENTERTAINMENT CORP | $1.14B | 139,636,593 | 45.44% | 54.56% | Net Selling | Net Buying | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $34.66M | 48,540,200 | 32.90% | 67.10% | Net Selling | Net Selling | ||
| IDYA | IDEAYA BIOSCIENCES INC | $2.95B | 87,666,408 | 92.57% | 7.43% | Net Buying | |||
| GHRS | GH RESEARCH PLC | $996.19M | 62,029,395 | 71.79% | 0.00% | ||||
| NAVN | NAVAN INC | $3.37B | 248,644,065 | 0.00% | 100.00% | Net Buying | Net Buying | ||
| RAPP | RAPPORT THERAPEUTICS INC | $1.26B | 47,661,138 | 75.35% | 24.65% | Net Selling | Net Selling | ||
| AIRG | AIRGAIN INC | $52.62M | 11,958,193 | 31.95% | 30.29% | Net Selling | Net Selling | ||
| KYTX | KYVERNA THERAPEUTICS INC | $367.01M | 43,796,170 | 43.64% | 56.36% | Net Buying | Net Buying | ||
| CBIO | CRESCENT BIOPHARMA INC | $149.07M | 13,892,516 | 13.39% | 86.61% | Net Buying | Net Buying | ||
| T | AT&T INC | $170.64B | 7,089,449,495 | 64.44% | 0.32% | Net Selling | Net Selling | ||
| ACRV | ACRIVON THERAPEUTICS INC | $59.64M | 31,555,126 | 54.09% | 45.91% | Net Selling | Net Selling | ||
| ANRO | ALTO NEUROSCIENCE INC | $476.25M | 31,066,335 | 53.94% | 21.66% | ||||
| APGE | APOGEE THERAPEUTICS INC | $4.83B | 68,320,229 | 87.21% | 5.61% | Net Selling | Net Selling | ||
| CYRX | CRYOPORT INC | $489.67M | 50,068,904 | 93.54% | 4.57% | Net Buying | Net Selling | ||
| CTMX | CYTOMX THERAPEUTICS INC | $999.67M | 169,435,395 | 81.09% | 12.77% | Net Selling | Net Selling | ||
| WYFI | WHITEFIBER INC | $847.84M | 38,259,989 | 19.31% | 71.35% | Net Buying | |||
| PEPG | PEPGEN INC | $358.87M | 68,748,224 | 82.51% | 9.24% | Net Buying | |||
| DNLI | DENALI THERAPEUTICS INC | $3.06B | 146,661,833 | 60.44% | 39.56% | Net Selling | Net Selling | ||
| KSCP | KNIGHTSCOPE INC | $42.58M | 11,508,862 | 7.54% | 71.23% | ||||
| CLYM | CLIMB BIO INC | $351.83M | 68,184,435 | 65.38% | 9.43% | Net Buying | Net Buying | ||
| IMRX | IMMUNEERING CORP | $322.85M | 64,569,967 | 40.33% | 21.88% | Net Buying | Net Buying | ||
| MRP | MILLROSE PROPERTIES INC | $4.91B | 166,003,497 | 64.26% | 0.24% | Net Buying | Net Buying | ||
| RLMD | RELMADA THERAPEUTICS INC | $289.67M | 73,333,622 | 10.55% | 4.82% | Net Buying | Net Buying | ||
| TTAN | SERVICETITAN INC | $8.58B | 93,646,634 | 45.53% | 54.47% | Net Selling | Net Selling | ||
| BIOA | BIOAGE LABS INC | $699.53M | 35,855,037 | 59.29% | 27.57% | Net Selling | Net Selling | ||
| CADL | CANDEL THERAPEUTICS INC | $315.12M | 54,898,303 | 41.26% | 31.10% | Net Buying | |||
| CRC | CALIFORNIA RESOURCES CORP | $4.26B | 83,711,931 | 87.78% | 12.22% | Net Selling | Net Buying | ||
| JBIO | JADE BIOSCIENCES INC | $719.51M | 46,004,205 | 62.53% | 37.47% | Net Buying | |||
| MGX | METAGENOMI INC | $60.07M | 37,546,751 | 15.98% | 34.26% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.